NCT00507494View on ClinicalTrials.gov

Influence of Pioglitazone for Renal Transplant Function in Diabetics

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Diabetes MellitusKidney TransplantationProteinuria
Interventions
DRUG

pioglitazone

Pioglitazone 30 mg o.d. tablet for 12 weeks or placebo o.d. tablet for 12 weeks in random order. After 12 wk treatment there is a 4 wk washout out which is followed by switch of study medication in a cross over fashion and a further 12 wk treatment.

Trial Locations (1)

01307

Nephrology, Department of Medicine, university hospital Dresden, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT00507494 - Influence of Pioglitazone for Renal Transplant Function in Diabetics | Biotech Hunter | Biotech Hunter